About Enhabit, Inc. 
Enhabit, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 42 Schemes (37.13%)
Foreign Institutions
Held by 78 Foreign Institutions (20.22%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
270 Million
(Quarterly Results - Dec 2025)
Net Profit:
-38 Million
Pharmaceuticals & Biotechnology
USD 690 Million (Micro Cap)
16.00
NA
0.00%
0.73
7.71%
1.22






